- ICH GCP
- Amerikanska kliniska prövningsregistret
- Klinisk prövning NCT03719222
Analysis of Tumor Mutations and Tumor Microenvironment Using Archival Paraffin-embedded Tumor Specimens
Genomic alterations have long been recognized as an important factor in tumor formation and drive tumor cell growth. However, the degree of genomic mutation (tumor mutation load, TMB) varies widely between tumors. In addition to gene mutations in tumor cells, the extent of immune cell infiltration in tumor tissues and the type and nature of immune cells (tumor microenvironment, TME) also play an important role in controlling tumor growth.
In recent years, more and more clinical studies have shown that the degree of genomic alteration (TMB) and tumor microenvironment (TME) have great potential in predicting a cancer patients' response to immunotherapy. Therefore, understanding the interaction and correlation between genomic alteration and tumor immune environment will not only deepen our understanding of tumor biology but also provide an important reference for developing immunotherapy treatment strategies for solid tumors.
Studieöversikt
Detaljerad beskrivning
This is a non-interventional, mono-centric retrospective study to be carried out in Chi Mei Medical Center (CMMC) in order to determine the association between the genomic alterations and gene expression level of immune-related genes in cancer. Samples in paraffin-embedded block of biopsies or surgical pieces (either primary tumor or metastases) will be analyzed. For each sample, clinically relevant data associated with treated cancer and needed for characterization of tumor microenvironment will be documented. No additional procedures besides those already used in the routine clinical practice will be applied to the patients. Treatment assignment will be done according to the current practice.
This trial is, through accessing to archival tumor materials, to establish the relationship between tumor mutation burden and tumor immune microenvironment for future immunotherapy strategy.
Studietyp
Inskrivning (Förväntat)
Kontakter och platser
Studiekontakt
- Namn: ACT Genomics ACT Genomics
- Telefonnummer: +886-2-2795-3660
- E-post: peifangchung@actgenomics.com
Studera Kontakt Backup
- Namn: Pei-Fang Chung
- Telefonnummer: 1303 +886-2-2795-3660
Studieorter
-
-
-
Taipei, Taiwan, 114
- Rekrytering
- ACT Genomics
-
Kontakt:
- Chung
- Telefonnummer: 1303 886-2-27953660
- E-post: peifangchung@actgenomics.com
-
-
Deltagandekriterier
Urvalskriterier
Åldrar som är berättigade till studier
- Barn
- Vuxen
- Äldre vuxen
Tar emot friska volontärer
Kön som är behöriga för studier
Testmetod
Studera befolkning
Beskrivning
Inclusion Criteria:
- Sample from patients with histologically documented cancer in target population.
Exclusion Criteria:
- Unusable sample or biologically deteriorated.
Studieplan
Hur är studien utformad?
Designdetaljer
Vad mäter studien?
Primära resultatmått
Resultatmått |
Åtgärdsbeskrivning |
Tidsram |
---|---|---|
Correlation between TMB and the expression level of PD-1/PD-L1
Tidsram: 12 months
|
To explore possible relationship between genomic alteration and expression of immune-related genes in solid tumor, tumor mutation burden (TMB) and PD-1/PD-L1 expression level are examined and such relationship will be calculated by Pearson's correlation coefficient.
|
12 months
|
Sekundära resultatmått
Resultatmått |
Åtgärdsbeskrivning |
Tidsram |
---|---|---|
Single point mutations, as part of cancer genomic profile
Tidsram: 12 months
|
To establish a cancer genomic profile for the Asian population, genomic alterations such as point mutations will be assessed by NGS-based ACTOnco assay.
|
12 months
|
Small insertions and deletions (Indel), as part of cancer genomic profile
Tidsram: 12 months
|
To establish a cancer genomic profile for the Asian population, genomic alterations such as small insertions and deletions will be assessed by NGS-based ACTOnco assay.
|
12 months
|
Copy number alterations, as part of cancer genomic profile
Tidsram: 12 months
|
To establish a cancer genomic profile for the Asian population, genomic alterations such as copy number alterations will be assessed by NGS-based ACTOnco assay.
|
12 months
|
Microsatellite instability, as part of genomic profile
Tidsram: 12 months
|
To establish a cancer genomic profile for the Asian population, genomic alterations such as microsatellite instability will be assessed by NGS-based ACTOnco assay.
|
12 months
|
TME gene expression profile, which consists of quantitative measurements of immune-related genes
Tidsram: 12 months
|
To establish an expression signature of tumor microenvironment (TME) in addition to PD-1 and PD-L1, >90 immune-related genes will be assessed by ACTTME assay via quantitative PCR
|
12 months
|
Concordance of TMB between ACTOnco assay and an externally validated assay
Tidsram: 12 months
|
To compare between calculated tumor mutation burden values (TMB, in mutations per megabase) resulting from different methodologies, concordance between two NGS-based assays will be expressed as positive predictive value (PPV) and negative predictive value (NPV).
|
12 months
|
Samarbetspartners och utredare
Sponsor
Samarbetspartners
Studieavstämningsdatum
Studera stora datum
Studiestart (Faktisk)
Primärt slutförande (Förväntat)
Avslutad studie (Förväntat)
Studieregistreringsdatum
Först inskickad
Först inskickad som uppfyllde QC-kriterierna
Första postat (Faktisk)
Uppdateringar av studier
Senaste uppdatering publicerad (Faktisk)
Senaste inskickade uppdateringen som uppfyllde QC-kriterierna
Senast verifierad
Mer information
Termer relaterade till denna studie
Nyckelord
Andra studie-ID-nummer
- ACTG-18001
Plan för individuella deltagardata (IPD)
Planerar du att dela individuella deltagardata (IPD)?
Läkemedels- och apparatinformation, studiedokument
Studerar en amerikansk FDA-reglerad läkemedelsprodukt
Studerar en amerikansk FDA-reglerad produktprodukt
Denna information hämtades direkt från webbplatsen clinicaltrials.gov utan några ändringar. Om du har några önskemål om att ändra, ta bort eller uppdatera dina studieuppgifter, vänligen kontakta register@clinicaltrials.gov. Så snart en ändring har implementerats på clinicaltrials.gov, kommer denna att uppdateras automatiskt även på vår webbplats .
Kliniska prövningar på non intervention
-
Cliniques universitaires Saint-Luc- Université...Avslutad
-
Hopital FochAvslutad
-
University of California, DavisAvslutadMelanom | Basalcellscancer | SkivepitelcancerFörenta staterna
-
AstraZenecaAvslutadBröstcancer | Onkologi | EpidemiologiAlgeriet
-
Perflow MedicalAvslutadIntrakraniell aneurysmSpanien, Israel, Bulgarien, Tyskland, Polen
-
University of UtahNational Aeronautics and Space Administration (NASA)AvslutadApné under procedurell sedering
-
Emory UniversityIndragen
-
Mayo ClinicAmerican Orthotic and Prosthetic AssociationAvslutadAmputation av nedre extremiteter ovanför knäet (skada)Förenta staterna
-
Andres Duque DuqueZimmer BiometOkänd
-
Walter C HembreeSmith & Nephew, Inc.Rekrytering